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sis but, in their article, there are many
other reasons for developing lactic ac-
idosis.
There is no precise presentation of
hemodynamic data. The cardiac index
is quite low. The blood pressure is
stable only with the administration of
dopamine, epinephrine, and nitro-
prusside infusion after disconnection
of the bypass machine. In fact, this
critically ill patient probably devel-
oped lactic acidosis during extracor-
poreal circulation (bicarbonate level,
19 mmol/L [19 mEq/L]), whereas epi-
nephrine therapy was not begun. In
their article we do not know if it is a
cardiac output (liter per minute minus
one [L/min-1]) or a cardiac index(liter per minute per square meter[L/min/m2]) and the patient has a 2-m2
surface. If pressure in the right side
of the heart is about 10 mm Hg, on
interpretation peripheral resistance is
at 2800 or 1333 dynes/cm-5/s-1. We
cannot calculate important data such
as the difference between arterial and
venous oxygen content (C [a-v] 02),
calcium dioxide, or peripheral oxygen
extraction based on the data. It is not
possible in these circumstances to ex¬
clude a type A lactic acidosis, espe¬
cially after cardiac surgery, usually
done with bypass hemodilution that
could be associated with a poor tissue
oxygen extraction.
The patient had a non-insulin-de¬
pendent diabetes mellitus and was
obese. In this circumstance, insulin
resistance is very common and the
high serum glucose level was probablydue to poor serum glucose control and
high postoperative stress.
Based on the available data, lactic
acidosis may be due to epinephrine or
other drug infusion, or to poor perfu¬
sion related to low cardiac output.Regression of lactic acidosis occurred
after improvement of hemodynamic
data and bypass-related disturbances.
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In Reply.\p=m-\Wethank Dr Guerin and
associates for their interest in our arti-
cle. We can reassure the reader that
the patient's cardiac index was
2.0 L/min/m2\p=m-\an excellent value for
an elderly patient after cardiac bypass
and who had not received pressors. We
emphasized in our report that the
pressors were administered em-
pirically, not because of hypotension,
oliguria, or any other evidence of poor
tissue perfusion. Thus, the scenario
for type A lactic acidosis is conspic-
uously absent. A serum bicarbonate
level of 19 mmol/L (19 mEq/L) is insuf-
ficient to support a diagnosis of lactic
acidosis, and may reflect the mild hy-
perlactatemia that accompanies gen-
eral anesthesia.1
We have never seen insulin resist-
ance of this severity in a diabetic pa-
tient, obese or otherwise, except in
the rare circumstances of insulin2 or
insulin receptor3 antibodies. The tem-
poral relationship between insulin re-
sistance and epinephrine administra-
tion is compelling, and the insulin
resistance waned rapidly and concur¬
rently as the epinephrine infusion rate
was decreased.
It is not clear what is meant by
"bypass related disturbance." The he¬
modynamic data provided indicate
that the patient was not hypotensive,
oliguric, or hypoxemic at any time.
Thus, we believe that this patient's
lactic acidosis and insulin resistance
were specifically induced by epi¬
nephrine.
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Pacing in Left Bundle-Branch
Block During Swan-Ganz
Catheterization
To the Editor.\p=m-\Weread with interest
the recent article by Morris and
colleagues1 that reported a fairly low
rate of developing complete heart
block (CHB) during Swan-Ganz (SG)
catheterization in patients with left
bundle-branch block (LBBB). We feel
that this is an important finding since
several sources, including recent ad-
vanced cardiac life support proceduralguidelines, recommend prophylactic
placement of a temporary transvenous
pacemaker prior to pulmonary artery
catheterization.2,3Although CHB and
hemodynamically significant brady-
cardia during this procedure may be
uncommon, its occurrence can be quite
dangerous and even catastrophic.
There are several additional points
that should be mentioned. The data
presented by Morris and associates
emanate from SG procedures in a crit-
ically ill population. It should be em-
phasized that these data may not be
applicable to patients with more ex-
tensive conduction system disease, eg,
patients with LBBB and a history of
syncope and patients with LBBB un-
dergoing permanent pacemaker im-
plantation or diagnostic catheteriza-
tion of the right side of the heart with
a hard wire. The authors correctly do
not make these extrapolations.
During SG catheterization in criti¬
cally ill patients with LBBB, two ad¬
ditional options merit consideration.
First, pacing can be accomplished, if
necessary, noninvasively by an exter¬
nal transthoracic pacing device.4 In
patients with LBBB, we routinely
have the external pacemaker paddles
near the chest prior to catheterization
of the right side of the heart, and this
can be applied and rapidly activated
during the procedure if CHB or he-
modynamically significant bradycar-
dia develops. Second, we frequently
use a balloon-tipped catheter with a
pacing-infusion port in the right ven¬
tricle. With the pace port SG catheter
in place, a reliable transvenous pace¬
maker in the right ventricle can be
rapidly inserted, if necessary. In pa¬
tients with LBBB that is of new onset
or of indeterminate age, particularly
during acute myocardial infarction, we
routinely have the external pacer cor¬
rectly positioned for immediate acti¬
vation and an SG with a pacing wire
through the right ventricular port
would be used. In our experience, this
type of pacemaker is reliable (at least
for the short term), does not signifi¬
cantly prolong the SG procedure, and
is not associated with a higher inci¬
dence of complications than with rou¬
tine SG catheterization alone. In ad¬
dition, placing the pacing wire via the
SG route does not require the same
degree of training or skill as placing a
hard, transvenous pacing wire, and
could easily be accomplished by in¬
ternists skilled in SG placement.
When pacing via the SG pace port
catheter, we recommend checking
pacemaker thresholds at least twice
daily. In patients with LBBB, manip¬
ulation of any SG catheter should be
performed, as much as possible, while
the catheter tip is in the right atrium;
catheter manipulation in the right ven¬
tricle should be avoided.
We feel that the use of an external
transthoracic pacemaker and an SG
with a pacing port should be strongly
considered for patients with LBBB(Continued on page 984.)
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who are undergoing catheterization of
the right side of the heart for hemo¬
dynamic monitoring.
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In Reply.\p=m-\DrsLavie and Gersh have
addressed several important issues re-
garding our study.1 They suggest that
in patients with left bundle-branch
block (LBBB), extensive symptomatic
conduction disease or the use of rigid
catheters pose additional risks for de-
veloping catheter-induced complete
heart block. We did not have the data
to support or refute this contention. It
is noteworthy that, in our study, the
incidence of catheter-induced com-
plete heart block in patients with
LBBB was extremely low, despite the
fact that these patients were critically
ill. The majority of patients in our
study had acute myocardial infarction,
congestive heart failure, and/or car-
diogenic shock. It is not clear if the
risk for catheter-induced complete
heart block in patients with LBBB is
greater with severe conduction disease
than with cardiogenic shock and/or
ongoing myocardial ischemia.
We agree with Drs Lavie and Gersh
that recent refinements in external
transthoracic temporary cardiac pac-
ing2 provide an excellent method for
rapidly initiating cardiac pacing,
should catheter-induced complete
heart block develop. Although exter¬
nal transthoracic pacing can be initi¬
ated immediately, there is failure to
capture in approximately 20%.2 Thus it
is imperative that the capability for
transvenous pacing be immediately
available. The transvenous pacing
wire can be inserted through the intro¬
ducer sheath or vein used for the initial
pulmonary artery catheterization, or
through a pacing-infusion port in the
pulmonary artery catheter itself, as
suggested by Drs Lavie and Gersh.
However, since catheter-induced com¬
plete heart block frequently occurs
when the catheter tip enters the right
ventricle initially, the pacing-infusion
port of the pulmonary artery catheter
may not be in a position that provides a
significant advantage for positioning
the pacer wire into the right ventricle.
Finally, catheter-induced heart block
will often resolve spontaneously by
withdrawing the offending catheter. If
the patient develops a transient
catheter-induced complete heart
block, it may be more prudent to place
a transvenous pacemaker first, before
the diagnostic pulmonary artery
catheterization.
Denise Morris, MD
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Diagnostic Value of the Medical
History
To the Editor.\p=m-\Iread "The Diagnostic
Value of the Medical History" in the
November issue of the Archives with
interest.1 I am not surprised that fac-
ulty and residents alike claim a high
interest in the medical history. I am
afraid that they are just spouting the
party line. Their actual skill in, use of,
and trust of the medical history may be
far from what they claim.
After having observed over 500
clinical interviews, I am still im-
pressed with the low general level of
skill. But no one ever claims to doubt
the value of the process; to do so would
be equivalent to an admission of incom-
petence. I recall one resident whom I
observed for a month while attending
on the medical service at our local
university hospital. The resident was
egregiously incompetent at relating to
people. We had several patients sign
out against advice while he was on our
service. I observed him interrupt an
intake history 11 times for phone calls,
several of a personal nature. He was
unable to hear his patients, insistently
controlled all interviewing with a se¬
ries of questions that the patient could
only answer "yes" or "no," and reliably
alienated his patients. He easily ig¬
nored all my comments about routes to
improvement. Then, at the end of the
month, he told me, over a cup of coffee,
that he was "ever grateful that he had
mastered history and physical ex¬
amination skills at a very early stage,"
since they stood him in such good stead
during his residency. I was struck
speechless.
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